BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Moderna’s Spikevax Scores Full FDA Approval while Omicron BA.2 Picture Emerges

  News that a subvariant of the Omicron variant has appeared in the U.S. and parts of Europe doesn’t seem like good news. The latest data suggest it’s 1.5 times more transmissible than the original Omicron variant, but not necessarily deadlier.

  January 31, 2022

   · 

  6 min read

   · 

  Mark Terry
• 

  Business

  Biogen Departure Train Chugs on as Two Board Members Exit

  One week after Johnna Rossell departed Biogen for Enzyvant, Biogen announced two more members of its board are leaving.

  January 31, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Pfizer Abandons Ionis’ Cardiovascular and High Triglyceride Program

  The decision came after the Phase IIb study results demonstrating a statistically significant decrease in non-HDL-C and statistically significant reductions in triglycerides and ANGPTL3.

  January 31, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Job Trends

  Rapid Expansion and Startups Spell a Fight for Biopharma Talent in Massachusetts

  Despite the massive financing from venture capitalists that poured into Massachusetts in 2021, Bay State biopharma companies are struggling to find enough talent to fill the number of available jobs.

  January 31, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  In Step Forward, FDA Approves First Bispecific Antibody for AMD and DME

  The FDA’s decision is based on positive results from several Phase III studies, including the TENAYA and LUCERNE clinical trials.

  January 31, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  U.S. Army Begins Human Trials of Pan Coronavirus Vaccine

  WRNMC researchers have found a way to create a vaccine that can recognize multiple spike proteins at once by using ferritin. Here’s more about pan coronavirus vaccine.

  January 31, 2022

   · 

  3 min read
• 

  Job Trends

  New Lilly Manufacturing Plant to Bring 600 Jobs to North Carolina

  Eli Lilly and Company announced plans to build a new manufacturing plant in Concord, North Carolina.

  January 31, 2022

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  The Epidemic of Obesity and its Impact on the Immune System

  You are what you eat, and your defense system notices that.

  January 31, 2022

   · 

  9 min read

   · 

  Ignacio Guerrero-Ros, Ph.D. (Guest Contributor)
• 

  Career Advice

  Effectively Using and Interpreting Body Language During Interview

  The use of body language during interview can ensure a good impression. Kinesics includes the use of posture, facial expression, movement, and gestures to communicate nonverbally.

  January 31, 2022

   · 

  6 min read

   · 

  Karen Walpole
• 

  Drug Development

  Positive Phase III Data Lifts Madrigal, Hopes for an Effective NASH Treatment

  Shares of Madrigal Pharmaceuticals went up in premarket trading after the company announced positive topline data from its Phase III assessment of resmetirom in non-alcoholic fatty liver disease.

  January 31, 2022

   · 

  3 min read

   · 

  Alex Keown